Hsbc Holdings PLC Tg Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 45,254 shares of TGTX stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,254

Previous 36,221 24.94%

Holding current value

$1.4 Million

Previous $644,000 64.29%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $155,457 - $228,354	9,033 Added 24.94%	45,254 $1.06 Million
Q2 2024 Aug 12, 2024	BUY	$13.32 - $19.19 $231,435 - $333,426	17,375 Added 92.19%	36,221 $644,000
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $245,374 - $401,419	18,846 New	18,846 $286,000
Q2 2022 Aug 11, 2022	SELL	$3.74 - $10.66 $37,699 - $107,452	-10,080 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $78,724 - $206,136	10,080 New	10,080 $98,000
Q4 2021 Feb 11, 2022	SELL	$15.2 - $35.51 $77,398 - $180,816	-5,092 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$21.78 - $40.45 $29,925 - $55,578	-1,374 Reduced 21.25%	5,092 $173,000
Q2 2021 Aug 13, 2021	SELL	$32.5 - $48.96 $2.04 Million - $3.07 Million	-62,734 Reduced 90.66%	6,466 $250,000
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $1.75 Million - $3.8 Million	69,200 New	69,200 $3.6 Million
Q1 2020 May 15, 2020	SELL	$7.14 - $15.99 $62,053 - $138,969	-8,691 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $20,716 - $45,494	4,062 Added 87.75%	8,691 $98,000
Q2 2019 Aug 13, 2019	SELL	$6.27 - $8.65 $19,637 - $27,091	-3,132 Reduced 40.36%	4,629 $40,000
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $31,199 - $62,398	7,761 New	7,761 $62,000
Q4 2018 Feb 13, 2019	SELL	$3.44 - $5.76 $14,190 - $23,760	-4,125 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.15 - $14.0 $957 - $2,604	186 Added 4.72%	4,125 $23,000
Q2 2018 Aug 10, 2018	BUY	$12.5 - $15.0 $49,237 - $59,085	3,939 New	3,939 $51,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.48B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Tg Therapeutics, Inc. Transaction History